• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

    10/22/24 4:16:16 PM ET
    $GEHC
    Medical Electronics
    Health Care
    Get the next $GEHC alert in real time by email
    SC 13G/A 1 eh240534014_13ga3-gehc.htm AMENDMENT NO. 3

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 3)*

     
    GE HEALTHCARE TECHNOLOGIES INC.
    (Name of Issuer)
     
    Common Stock, $0.01 par value
    (Title of Class of Securities)
     
    36266G 107
    (CUSIP Number)
     
    September 30, 2024
    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

      ☐ Rule 13d-1(b)
      ☐ Rule 13d-1(c)
      ☒ Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

       

     

     

    CUSIP No. 36266G 107 SCHEDULE 13G Page 2 of 6

     

     

    1

    NAME OF REPORTING PERSON

     

    General Electric Company

     
    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     

    (a)  ☐

    (b)  ☐

    3

    SEC USE ONLY

     

     

     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    New York

     

    NUMBER OF

    SHARES

    BENEFICIALLY OWNED

    BY EACH REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    13,281,302 (See Note 1)

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    13,281,302 (See Note 1)

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    13,281,302 (See Note 1)

     
    10

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    2.9% (See Note 2)

     
    12

    TYPE OF REPORTING PERSON

     

    CO

     

     

    Note 1: As of September 30, 2024, General Electric Company, operating as GE Aerospace (“GE Aerospace”), beneficially owned 13,281,302, or approximately 2.9%, of the shares of common stock (“Common Stock”) outstanding of GE HealthCare Technologies Inc. (the “Company”). Pursuant to a Stockholder and Registration Rights Agreement, dated as of January 2, 2023 (the “Stockholder and Registration Rights Agreement”), between GE Aerospace and the Company, GE Aerospace granted to the Company a proxy to vote the shares of Common Stock owned by GE Aerospace in proportion to the votes cast by the Company’s other stockholders.

     

    Note 2: The denominator for this calculation is based on 456,662,253 shares of Common Stock outstanding as of July 24, 2024, as reported in the Company’s Form 10-Q filed with the U.S. Securities and Exchange Commission on July 31, 2024.

     

       

     

     

    CUSIP No. 36266G 107 SCHEDULE 13G Page 3 of 6

     

     

    Item 1. (a) Name of Issuer:
         
        GE HealthCare Technologies Inc.
         
      (b) Address of Issuer’s Principal Executive Offices:
         
        500 W. Monroe Street, Chicago, Illinois 60661
       
    Item 2. (a) Name of Person Filing:
         
        General Electric Company
         
      (b) Address of Principal Business Office, or if none, Residence:
         
        1 Neumann Way, Evendale, OH 45215
         
      (c) Citizenship:
         
        New York
         
      (d) Title of Class of Securities:
         
        Common Stock, $0.01 par value
         
      (e) CUSIP Number:
         
        36266G 107
         
    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
         
      (a) [__] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
      (b) [__] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
      (c) [__] Insurance Company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
      (d) [__] Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
      (e) [__] An investment adviser in accordance with Rule 240.13d-1(b)(1)(ii)(E);
      (f) [__] An employee benefit plan or endowment fund in accordance with Rule 240.13d-1(b)(1)(ii)(F);
      (g) [__] A parent holding company or control person in accordance with Rule 240.13d-1(b)(1)(ii)(G);
      (h) [__] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
      (i) [__] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); or
      (j) [__] Group, in accordance with §240.13d-1(b)(1)(ii)(K).
          If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ___________________________.
      (k) [__] A group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:  ___________________________.

     

     

       

     

     

    CUSIP No. 36266G 107 SCHEDULE 13G Page 4 of 6

     

     

    Item 4. Ownership.
       
     

    (a)-(c)

     

    The responses of the Reporting Person to Rows 5, 6, 7, 8, 9 and 11 in the cover page to this Section 13G are incorporated herein by reference.

     

    Additional Note: Pursuant to the Stockholder and Registration Rights Agreement, GE Aerospace granted to the Company a proxy to vote the shares of Common Stock owned by GE Aerospace in proportion to the votes cast by the Company’s other stockholders.

     

    Item 5. Ownership of Five Percent or Less of a Class.
       
      If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☒
       
    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
       
      Not applicable.
       
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
       
      Not applicable.

     

     

       

     

     

    CUSIP No. 36266G 107 SCHEDULE 13G Page 5 of 6

     

     

    Item 8. Identification and Classification of Members of the Group.
       
      Not applicable.
       
    Item 9. Notice of Dissolution of Group.
       
      Not applicable.
       
    Item 10. Certifications.
       
      Not applicable.

     

     

     

     

     

       

     

     

    CUSIP No. 36266G 107 SCHEDULE 13G Page 6 of 6

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: October 22, 2024

     

      GENERAL ELECTRIC COMPANY  
           
           
      By: /s/ Brandon Smith  
        Name: Brandon Smith  
        Title: Chief Corporate, Securities & Finance Counsel  

     

     

     

     

       

     

     

    Get the next $GEHC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GEHC

    DatePrice TargetRatingAnalyst
    5/5/2025$73.00Sell → Neutral
    UBS
    3/11/2025$85.00 → $100.00Neutral → Buy
    Goldman
    1/8/2025$95.00 → $103.00Hold → Buy
    Jefferies
    9/26/2024$84.00 → $74.00Neutral → Sell
    UBS
    9/18/2024$100.00Neutral → Buy
    BTIG Research
    9/9/2024$90.00Neutral
    JP Morgan
    8/6/2024$100.00Buy
    Stifel
    5/30/2024$87.00Neutral
    Goldman
    More analyst ratings